Efficacy and safety of canagliflozin (CANA), a sodium glucose co-transporter 2 inhibitor (SGLT2), in older subjects with type 2 diabetes mellitus B. Bode,K. Stenlof,D. Sullivan,A. Fung, K. Usiskin,G. MeiningerDIABETOLOGIA（2012）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
